IN THE NEWS: A new study has found that the regular use of aspirin could lower colorectal cancer risk, particularly among individuals with lifestyle risk factors such as smoking or obesity. However, their risk was still not as low as individuals with the healthiest lifestyle, whose risk was low whether…
Scientists at UCSF discovered how kids were developing multisystem inflammatory syndrome in children (MIS-C), a mysterious, life-threatening condition following a COVID infection.
Researchers at UC Davis have developed a noninvasive tool to track the neurons and biomolecules activated in the brain by psychedelic drugs like LSD and psilocybin.
IN THE NEWS: The key to All of Us, a national research effort to collect and study the health data of more than 1 million Americans, is its inclusivity, says Hoda Anton-Culver, PhD, a Donald Bren Professor and Distinguished Professor of medicine at UC Irvine. Since 2018, UC Irvine has…
Scientists at UCSF and Contineum Therapeutics have developed a drug that spurs the body to replace the protective insulation around nerve cells, myelin, that is lost in multiple sclerosis. If it works in people, it could be a way to reverse the damage caused by the disease.
Nearly 60 fellows from five groups gather in Sacramento for the largest gathering of the Betty Irene Moore Fellowship for Nurse Leaders and Innovators.
A Q&A with Margot Kushel, director of the UCSF Benioff Homelessness and Housing Initiative, in the wake of the Supreme Court decision that opens the door for cities and counties, including in California, to begin clearing homeless encampments and imposing penalties for violations.
IN THE NEWS: Relying on the presence or absence of a single symptom to diagnose neurological conditions such as autism or concussion is a concerning trend in pediatrics, writes child neurologist Dr. Sharief Taraman in Psychology Today. The potential for misdiagnosis and delayed treatment increases when certain hallmark symptoms of…
IN THE NEWS: The recent FDA approval of a new oral medication provides an effective therapy for people suffering from severe hair loss, said UCI Health dermatologist Dr. Natasha Mesinkovska. On July 26, the U.S. Food and Drug Administration approved the oral JAK inhibitor Leqselvi™ (deuruxolitinib) to treat adults with…
Health Media Contacts
Find the best contact for health-related media inquiries.
